China Wuhan Desheng Biochemical Technology Co., Ltd Company News

Policy background and industry turbulence On April 4, 2025, the Tariff Commission of the State Council issued a notice imposing a 34% tariff on imported goods originating in the United States. This policy was officially implemented at 12:01 pm on April 10. This tariff policy, known as "reciprocal retaliation," has had a structural impact on the in vitro diagnostics (IVD) industry. Data shows that about 15% of China's annual imports of IVD products come from domestic production in the United States, and after the implementation of the new policy, the comprehensive tax rate for related products has exceeded 50%. Supply Chain Response Strategies for Foreign Enterprises (1) In the field of reagents, molecular diagnostic reagents are the first to bear the brunt, and the cost of core raw materials such as nucleic acid extraction kits has increased by more than 30% after tax. Due to the locked in bid price for centralized procurement, multinational enterprises need to absorb cost pressure on their own. (2) Equipment field: High end equipment core modules such as fully automated biochemical immune assembly lines still rely on imports, and equipment procurement costs have surged by 34% after tax increases. The equipment update cycle of medical institutions may be extended by 6-12 months. (3) Emergency measures: Some foreign enterprises have launched the "bonded warehouse+fast customs clearance" plan, striving to complete customs clearance within the buffer period of May 13th to avoid the transfer of tariff costs. Accelerating the process of domestic substitution (1) In the field of biochemical immunology, domestic enterprises have seized the market through the "equipment+reagent" binding model. The latest centralized procurement data from a certain province shows that the share of imported reagents has been reduced to 10% -20%. (2) Raw material breakthrough: The order volume of core raw materials such as quality control matrix and calibration products has surged by 180% month on month, and the localization rate of key raw materials has exceeded 60%. (3) Technological upgrade: Domestic enterprises have launched zero consumable assembly line systems, reducing operation and maintenance costs by 30% through IoT technology. Channel ecological reconstruction (1) The profit margin of agents is compressed: the gross profit margin of imported reagent agents has decreased from 25% to 5%, and some products have experienced price inversion. (2) Service model innovation: A new cooperation model of "equipment leasing+testing volume sharing" has emerged, and the proportion of service revenue has increased to 40%. (3) Channel transformation: Within two months, the number of domestic equipment channel contracts has increased fivefold, and the response time for after-sales service has been shortened to 24 hours. Special field impact (1) Colloidal gold testing: 80% of core raw materials rely on imports from the United States, with production costs skyrocketing by 34%, and some companies losing 0.3 yuan per product. (2) Life science instruments such as PCR machines and ultracentrifuges rely entirely on imported pricing, and a university's budget of 5 million yuan for equipment requires an additional 1.7 million yuan in tariffs. Industry Development Trends (1) The probability of domestic equipment installation in tertiary hospitals is expected to exceed 30%, and in secondary hospitals it is expected to reach 60% (2) The coverage rate of the self-developed raw material system has been increased to 75% (3) The market size of testing services is expected to grow by 25% annually Hubei Xindesheng Material Technology focuses on the research and development of IVD core raw materials, and its independently developed biochemical reagent raw materials and quality control matrix have been certified. The company provides a full chain service from raw material development to technical validation, helping to improve the quality and reduce costs of diagnostic reagents. New Desheng's preferred partner for localizing raw materials!

The Chinese in vitro diagnostic market is undergoing an epic power restructuring. The UBS 2025 report reveals that the market share of local enterprises has jumped from 37% in 2019 to 47% in 2023, achieving comprehensive breakthroughs in two strategic highlands: immunoassays (market size accounting for 40%) and clinical chemistry (21%). Behind this transformation is the superposition resonance of triple kinetic energy. Technological Breakthrough: From Imitation and Innovation to Global Leadership The COVID-19 pandemic has become a watershed in the industry. Previously, foreign giants monopolized 90% of high-end testing equipment, and local enterprises were trapped in a passive situation of "following reagents and importing equipment". But after 2020, three key variables have overturned the competitive landscape: the emergence of a 40 billion level testing demand due to sudden public health emergencies, the opening of capital transfusion channels through the Science and Technology Innovation Board, and the breakthrough of the 75% threshold for supply chain localization rate. The R&D investment intensity of local enterprises reached 12.6%, which is two percentage points higher than that of foreign investment. Top enterprises have completed nearly 200 immunization testing project layouts, with 40% more testing menus than international leading enterprises. The localization rate of fully automatic chemiluminescence analyzer has exceeded 75%, and the single machine detection speed has reached 900 tests/hour, which is 50% higher than international competitors. A field survey conducted at a tertiary hospital in Suzhou showed that the daily detection volume of domestic equipment increased by 28%, and operating costs decreased by 35%, completely breaking the cognitive paradox that "imported equipment is more economical". Policy Engine: Centralized Procurement Reshaping the Logic of Value Distribution The pilot program of chemiluminescence centralized procurement is like toppling a domino, triggering a nationwide policy resonance. Volume based procurement reconstructs the market through a triple mechanism: price suppression (with an average decrease of 52%), procurement volume binding (with a mandatory increase in the proportion of domestic equipment), and service point system (with localized services included in the scoring). In a bidding case of a tertiary hospital, domestic enterprises achieved a turnaround in the technical scoring stage with the "iron triangle" of fully automated assembly lines, hundred item testing menus, and localized maintenance. This policy combination has brought structural changes: the proportion of domestic equipment procurement in tertiary hospitals has soared from 18% in 2019 to 70%, and the contribution rate of high-end market sales has exceeded 50%. The more profound impact lies in the transformation of business models - leading enterprises are beginning to evolve towards an ecological competition of "equipment+reagents+data services", and AI assisted diagnostic systems have covered 3000 medical institutions. Supply chain revolution: from bottleneck to autonomous and controllable The self-sufficiency rate of key raw materials has jumped from 58% before the epidemic to 89%, and this silent supply chain revolution has reshaped the foundation of industry competition. Domestic leading enterprises have successfully reduced the cost of chemiluminescence reagents by 40% and shortened the research and development cycle of new products to 9 months by controlling core raw material technologies such as monoclonal antibodies through strategic mergers and acquisitions. In a certain IVD industrial park in Hangzhou, the vertical integration system of raw materials, equipment, and reagents forms a 72 hour rapid response capability, which has a crushing advantage compared to the overseas transfer cycle of 3-6 months for foreign-funded enterprises. The control of the entire industry chain is generating spillover effects: a quality control product research and development center has achieved a consistency of 99.8% in test results, exceeding international certification standards; Microfluidic chip technology has propelled POCT detection into the era of "chip laboratories". After years of development, Hubei Xindesheng Material Technology will uphold innovative concepts, continuously improve product quality and service levels, and contribute to the development of the IVD industry.

In the vast world of biological science research, buffer solutions are like a silently dedicated 'invisible guardian', playing an irreplaceable role in maintaining the stability of experimental systems. From cell culture to protein purification, from enzymatic reactions to gene expression analysis, every experimental step cannot be separated from the precise regulation of buffer solutions. Among numerous buffer solutions, HEPES buffer (4-hydroxyethylpiperazine ethanesulfonic acid) stands out with its unique properties and has become a shining star in the field of protein research. The mystery of HEPES' unique charge neutralization ability (1) Neutralize protein charge and reduce diffusion coefficient As the main carrier of life activities, the surface charge state of proteins has a crucial impact on their function, stability, and cellular internalization process. When proteins are in a specific physiological environment, their surface carries a certain amount of charge, which can repel or attract each other, thereby affecting the spatial conformation and interactions of proteins. HEPES can cleverly interact with the surface charges of proteins, reducing their diffusion coefficient. The decrease in diffusion coefficient means that the movement speed of proteins in solution slows down, which helps proteins maintain a relatively stable state and reduces structural damage or functional loss caused by rapid movement. (2) Compared with traditional buffer solutions, the advantages are fully demonstrated Compared with traditional buffer solutions such as Tris HCl, HEPES exhibits unparalleled advantages in neutralizing protein charges. Tris HCl is also a commonly used buffer, but it is difficult to achieve the same effect as HEPES in promoting protein stability and cellular internalization. Tris HCl may to some extent affect the charge distribution of proteins or cause other non-specific interactions with proteins, thereby interfering with their normal function. HEPES, with its unique chemical structure and properties, can more accurately neutralize protein charges and provide a more suitable environment for proteins. Charge neutralization assisted protein transfection: mechanism and application (1) Promote protein adsorption and internalization on the cell membrane HEPES creates favorable conditions for protein adsorption and endocytosis on cell membranes by neutralizing protein charges. The cell membrane is an important barrier for the exchange of substances between cells and the external environment. In order for proteins to enter the interior of cells, they first need to find a suitable "foothold" on the cell membrane. After neutralizing the protein charge, HEPES enables the protein to interact more tightly with specific receptors or binding sites on the cell membrane, increasing the protein's residence time and binding strength on the cell membrane. This interaction promotes the endocytosis of the cell membrane, just like the cell extending its "arm" to "pull" proteins into the cell, thereby significantly improving the transfection efficiency of proteins. (2) Provide scientific basis for protein transfection This unique charge neutralization mechanism provides a solid scientific basis for the application of HEPES in protein transfection. Protein transfection is a crucial step in fields such as gene therapy and protein drug development. By introducing specific proteins into cells, it is possible to regulate cellular functions, study gene expression, and diagnose and treat diseases. HEPES, with its excellent charge neutralization ability, can effectively promote the internalization of proteins, allowing more proteins to successfully enter the cell and fulfill their biological functions. This not only improves the success rate of the experiment, but also provides more reliable and efficient technical means for related research. conclusion HEPES has shown great potential and application value in protein research due to its unique charge neutralization ability. It not only provides strong guarantees for protein stability and cellular internalization, but also opens up new avenues for research in related fields. In future explorations, let us join hands with HEPES to uncover more mysteries of life sciences and contribute more wisdom and strength to human health and well-being. Hubei Xindesheng Material Technology specializes in the production of HEPES and other biological buffering agents. The products have high purity, good buffering capacity, and affordable prices, providing product support for related experiments. If you are also interested in our products, please feel free to contact me!

HEPES: The 'pH Guardian' of Protein Transfection 1. Precise buffering to safeguard the transfection environment Protein transfection is a key technology in gene function research, drug development, and cell therapy, but this process requires extremely high stability in the cell culture environment. HEPES buffer, as a non-ionic buffer, has the core advantage of accurately maintaining the pH stability of the culture medium. During cellular metabolism, the acidic substances produced by the dissolution of CO ₂ may disrupt pH balance, and HEPES can quickly neutralize these acidic substances, avoiding the impact of pH fluctuations on transfection efficiency. Experiments have shown that the use of HEPES buffering system can effectively reduce cell damage caused by pH imbalance, providing an ideal microenvironment for protein transfection. 2. Compatible with complex systems to improve transfection efficiency The compatibility between transfection reagents (such as liposomes, polyethyleneimine, etc.) and buffering agents directly affects the transfection efficiency. The chemical structure of HEPES is stable and does not react with transfection reagents, ensuring the complete formation of transfection complexes. In addition, HEPES can efficiently buffer at low concentrations, avoiding interference with cell membrane permeability caused by high ion concentrations, thereby improving the delivery efficiency of exogenous proteins.   The multidimensional advantages of HEPES: from cell protection to experimental optimization 1. Cell protection: reduce oxidative stress and toxicity During the transfection process, cells may produce a large amount of reactive oxygen species (ROS) due to metabolic disorders, leading to oxidative stress damage. The antioxidant properties of HEPES can inhibit the generation of ROS and reduce cellular oxidative damage. At the same time, its non-ionic structure avoids the metal ion chelation problem that traditional buffering agents may cause, reducing the toxic effect of metal ions on cells. Research has shown that the HEPES buffer system can significantly improve the survival rate of transfected cells, ensuring the reliability of experimental results. 2. Experimental optimization: Simplify operations and improve repeatability HEPES can be quickly dissolved at room temperature without complex processing, and can be directly added to the culture medium, simplifying the experimental process. It has high chemical stability and can maintain buffering performance even in long-term cultivation, ensuring batch consistency in transfection experiments. In addition, HEPES has no inhibitory effect on cell growth and supports the sustained proliferation and functional expression of transfected cells, providing assurance for subsequent research. Innovative application scenarios of HEPES in protein transfection 1. Gene editing and CRISPR technology In CRISPR/Cas9 transfection experiments, the HEPES buffer system significantly improved the delivery efficiency of sgRNA and Cas9 protein, enhancing the accuracy of gene editing. Its mild buffering performance helps to reduce non-specific nuclease activity, decrease off target effects, and provide a reliable tool for gene therapy research. 2. Recombinant protein production For cell lines that require efficient expression of exogenous proteins, such as CHO cells, the HEPES buffer system can maintain the stability of the endoplasmic reticulum (ER) environment, promote correct protein folding and secretion, improve protein yield and purity, and meet the needs of the biopharmaceutical industry. 3. Transfection of stem cells and immune cells In iPSC reprogramming and CAR-T cell preparation, the buffering performance of HEPES can protect sensitive cells from osmotic shock, maintain cell pluripotency or immune activity, and provide technical support for regenerative medicine and tumor immunotherapy.   Conclusion The application of HEPES in protein transfection is not only a technological breakthrough, but also an innovation in the paradigm of life science research. Hubei Xindesheng Material Technology will continue to be customer-oriented and driven by technological innovation, providing better products and services for global researchers and jointly promoting life sciences to new heights. Hubei Xindesheng Material Technology specializes in the production of HEPES and other biological buffering agents. The products have high purity, good buffering capacity, and affordable prices, providing product support for related experiments. If you are also interested in our products, please feel free to contact me!  

In molecular biology experiments, DNA precipitation and extraction are fundamental steps in gene research, cloning technology, and diagnostic reagent development. During this process, the selection of biological buffering agents directly affects the purity, integrity, and experimental efficiency of DNA. Trimethylmethylaminoethanesulfonic acid (TES buffer), as an efficient buffering agent, has demonstrated significant advantages in the field of DNA manipulation due to its unique physicochemical properties and stability. The chemical properties of TES: the scientific basis for buffering capacity TES, The chemical name is 2- [(trihydroxymethyl) methylamino] -1-ethanesulfonic acid, and the sulfonic acid groups and multiple hydroxyl groups in its molecular structure endow it with excellent buffering ability. At room temperature, the pKa value of TES is 7.5, and the effective buffering range covers pH 6.8-8.2, which precisely matches the activity and DNA stability requirements of most biological enzymes. Compared to traditional buffer Tris (buffer range pH 7.0-9.0), TES exhibits stronger resistance to temperature changes and can effectively avoid the risk of low-temperature induced DNA degradation. Triple core role in DNA extraction 1. Cell lysis and protein removal During the cell lysis stage, TES inhibits the activity of DNA enzymes and protects genomic DNA from degradation by chelating divalent metal ions (such as Mg ² ⁺, Ca ² ⁺) in the solution. Its buffer system simultaneously maintains the optimal pH for proteases such as proteinase K (usually pH 7.5-8.0), accelerating the breakdown of cell membranes and protein degradation. Experiments have shown that the protein removal efficiency of the lysis system using TES buffer is improved by about 25% compared to traditional methods, laying a good foundation for subsequent purification steps. 2. Selective regulation of DNA precipitation TES is a composite buffer solution composed of Tris hydrochloric acid, EDTA, and SDS (TES-EDTA-SDS), which achieves selective precipitation of DNA by adjusting the ionic strength of the solution. At high salt concentrations (such as 2.5M NaCl), the sulfonic acid groups of TES act through electrostatic shielding, promoting the repulsion of phosphate groups between DNA molecules and forming a soluble state; When the salt concentration drops below 0.5M, DNA aggregates and precipitates due to exposure of the phosphate backbone. This process has a repulsive effect on RNA and other impurities, resulting in DNA recovery purity of over 95%. 3. Enzyme activity protection The protective effect of TES buffer on enzyme activity is particularly prominent in limiting enzyme cleavage reactions. Research has shown that the cutting efficiency of restriction enzymes (such as EcoRI) using TES reaction system is 18% -22% higher than that of HEPES buffer. Its stable pH environment reduces enzyme conformational changes, prolongs the linear period of enzyme cleavage reactions, and ensures the accuracy of gene editing experiments. Conclusion TES buffer exhibits irreplaceable advantages in DNA precipitation and extraction due to its excellent pH stability, metal ion chelation properties, and enzyme protection effect. By optimizing experimental conditions and exploring new application scenarios, TES will continue to drive molecular biology research towards more efficient and precise directions. For researchers, mastering the buffering mechanism and application techniques of TES is undoubtedly the key to improving the success rate of experiments. TES buffer is not only used in cosmetics. Its buffering properties make it play an important role in protein analysis, enzyme activity determination, and cell culture. As an advantageous supplier of TES buffer, Desheng can provide high-purity and diverse types of buffer raw materials. Customers can complete one-stop procurement, saving time and costs. If you have any relevant intentions, please feel free to contact us for purchase at any time!

In molecular biology experiments, electrophoresis analysis is the core technology for separating and identifying biomolecules such as nucleic acids and proteins. The choice of buffer directly affects the accuracy and reliability of experimental results, and MOPS (3- (N-morpholino) propanesulfonic acid) buffer exhibits significant advantages in electrophoretic analysis due to its unique chemical properties and stability. Chemical properties and buffering mechanism of MOPS MOPS is an organic compound containing sulfonic acid groups and a morpholine ring, with a pKa value of 7.2 and an effective buffering range of pH 6.5-7.9. This range is close to the physiological pH value, which gives MOPS a natural advantage in simulating the biological environment in research. The buffering mechanism of MOPS maintains solution stability over a wide pH range through protonation and deprotonation reactions. Its moderate ion strength ensures both electric field uniformity and reduces non-specific interactions, providing an ideal migration environment for biomolecules. The core advantages of MOPS in electrophoretic analysis 1. Protect the MOPS buffer solution of biomolecules to maintain a stable pH environment during electrophoresis, effectively preventing degradation or denaturation of RNA and proteins due to acid-base changes. Compared with traditional buffering agents, MOPS can significantly reduce the hydrolysis reaction of nucleic acids and maintain the natural conformation of proteins. Experiments have shown that RNA electrophoresis using MOPS buffer improves band clarity by about 30% compared to TAE buffer. 2. Improve the separation efficiency. The weak alkaline properties (pH 7.0-7.5) of MOPS provide uniform charge distribution for biomolecules and promote their effective migration in an electric field. In protein electrophoresis, the low viscosity property of MOPS reduces sample diffusion by about 25% and significantly improves resolution. Compared with TBE buffer, MOPS exhibits higher peak symmetry when separating proteins smaller than 15kDa. 3. Multi scene compatibility MOPS buffer is compatible with agarose gel, polyacrylamide gel and other electrophoresis systems. In Northern hybridization, MOPS as a transmembrane buffer can reduce non-specific binding of RNA to the membrane and improve hybridization efficiency. Its non fluorescent interference characteristic gives it an advantage in fluorescence labeled electrophoresis. Comparison between MOPS and other buffering agents 1. TAE buffer: TAE has weak buffering capacity, but is easy to prepare and cost-effective, suitable for electrophoretic analysis of large molecular DNA fragments. 2. TBE buffer: It has high buffering capacity and is suitable for the separation of small molecule DNA fragments, but it may lead to RNA degradation in RNA electrophoresis. Conclusion MOPS buffer is becoming an important tool in the field of electrophoretic analysis due to its unique advantages. With the deepening of research, MOPS will play a key role in more fields and promote the innovative development of biotechnology. Whether in basic research or industrial applications, MOPS is known for its stable performance and outstanding performance. Whether in protein purification, electrophoresis, or cell culture, MOPS can provide reliable pH stability, helping researchers obtain accurate and reproducible experimental results. Desheng is a professional manufacturer of biological buffering agents, established for more than ten years. It has rich experience in research and development, production, and product knowledge, and can provide customers with a large amount of technical support and after-sales guarantee. The biological buffer products currently produced include MOPS, TRIS, HEPES, TAPS, CAPS, BICINE, EPPS, PEP and a series of other biological buffer solutions. If you need them, please feel free to contact us at any time!

In today's rapidly developing global medical testing technology, chemiluminescence reagents, as "precise probes" in the field of in vitro diagnostics (IVD), are writing a differentiated market landscape with changes in economic and medical needs in different regions. From the vibrant vitality of emerging markets in Asia to the stable landscape of mature markets in Europe and America, the competition and opportunities in this blue ocean reflect profound changes in the global healthcare industry. 1, Asia: Accelerating the Start of Growth Engines On this vibrant land of Asia, the chemiluminescence reagent market is reshaping the industry landscape at an astonishing speed. When the skyscrapers in Lujiazui, Shanghai and the technology park in Bangalore, India shine together, it is the awakening of health awareness among hundreds of millions of people. The wave of urbanization has not only changed the skyline, but also promoted the upgrading of primary healthcare facilities - from tertiary hospitals to community clinics, the popularization of detection equipment has enabled chemiluminescence technology to reach a wider range of people. China and India, as dual drivers of regional development, demonstrate a unique development logic. In the medical device industry park in Shenzhen, the chemiluminescence detection system developed by local enterprises has been able to achieve "same day sampling, same day results", and this efficiency innovation is radiating from big cities to county-level medical centers. The graded diagnosis and treatment policy implemented by the government is like a conveyor belt, delivering advanced testing technology to every corner that needs it. The thriving private healthcare system in India has created a unique development model by combining the introduction of international equipment with localized reagents. It is worth noting that innovative forces are rising on this land. A biotechnology company located in Suzhou has reduced testing costs by 30% by improving reagent formulations, enabling remote health centers to conduct thyroid function screening. This down-to-earth technological innovation is a vivid footnote to the vitality of the Asian market. 2, Europe and America: Maintaining Integrity in Mature Markets and Emerging Innovation The European and American markets spanning the Atlantic exhibit different developmental rhythms. At the medical exhibition in Munich, Germany, the century old brand's chemiluminescence instrument still occupies the C position, but the most discussed topic in front of the booth is no longer simply parameter competition, but how to extend the equipment's life cycle through intelligent transformation. This transformation reveals the survival philosophy of mature markets: mining service value in stock competition. The strict healthcare regulatory system in Europe is like a double-edged sword. It not only ensures the stability of testing quality, but also makes the admission of new products like crossing layers of checkpoints. But wise practitioners have found a way to break through - an Italian company has combined a chemiluminescence platform with blockchain technology to create a fully traceable detection system that meets regulatory requirements and creates new service premiums. The arena of the North American market is filled with "songs of ice and fire". In the biotechnology cluster area of Boston, startups are attempting to disrupt traditional testing models with miniaturized devices, while established giants are consolidating their moats by acquiring innovative reagent companies. This continuous technological iteration ensures that even in the context of slowing market growth, the spark of innovation continues to thrive. 3, Future vision: Technology accessibility and value reconstruction From a global perspective, the regional differences in the chemiluminescence reagent market are essentially a mirror reflection of the uneven distribution of medical resources. While the Asian market is still addressing the question of 'whether or not', the European and American markets are already exploring higher pursuits of 'whether or not'. This development gap precisely provides space for technology transfer and model innovation. It is worth looking forward to that the digital wave is blurring geographical boundaries. A cloud based quality control system developed by a Singaporean company can provide real-time data support for both community hospitals in Bangkok and private clinics in Chicago. This technology sharing that transcends geographical limitations may reshape the rules of competition in the future. Under the wave of silver hair in an aging society, the demand for testing has grown beyond geographical limitations. The Alzheimer's disease early screening kit developed in Japan has been widely used in elderly physical examinations in the Yangtze River Delta region after localization and improvement by Chinese companies; The tumor marker detection scheme developed by Germany has also been produced in India through technology authorization. This global collaborative innovation ecosystem is writing a new narrative for industry development.

Industry opportunities under the global economic development trend Against the backdrop of a "K-shaped recovery" in the global economy, the in vitro diagnostic industry is facing opportunities for differentiated development. In 2023, the global medical device market size will exceed $580 billion, with the in vitro diagnostic sector continuing to increase to 13.2%. As the largest individual market, the export value of IVD products in the United States increased by 8.7% year-on-year, while the European Union's market concentration has significantly increased after the implementation of the In Vitro Diagnostic Medical Device Regulation (IVDR), with the top ten companies having a market share exceeding 65%. As the world's second-largest medical market, China's in vitro diagnostic market is expected to reach 125.8 billion yuan in 2023. With a stable GDP growth rate of around 5% in the new normal of the economy, the industry is exhibiting countercyclical growth characteristics. It is worth noting that the export volume of diagnostic reagents exceeded 30 billion yuan for the first time, among which the contribution rate of countries along the "the Belt and Road" increased to 37%, marking a new stage in the global layout of the industry. The market transformation brought about by economic structural adjustment Driven by the development pattern of "dual circulation", the domestic in vitro diagnostic market presents three major structural changes: 1. Consumer upgrading drives an increase in the proportion of high-end products, with an annual increase of 25% in the installed capacity of chemiluminescence detection equipment. The number of single machine detection projects in tertiary hospitals has exceeded 150 2. The rapid rise of the county-level medical market has led to a 41% year-on-year increase in the purchase of POCT equipment by primary healthcare institutions in 2023 3. The innovation of service models is accelerating, and the revenue growth rate of third-party medical testing services has reached 34%, significantly higher than the sales growth rate of traditional products Of particular note is the surge in demand for products that combine cost-effectiveness and diagnostic accuracy among medical institutions in the context of healthcare payment reform (DRGs/DIP). In 2023, the daily average detection volume of a single fully automatic biochemical analyzer in China exceeded 2000 tests, which is three times higher than five years ago, confirming the trend of equipment upgrading driven by operational efficiency. The dual empowerment effect of policy environment The coordinated efforts of regulatory policies and industrial policies are reshaping the competitive landscape of the industry. After the implementation of the new version of the "Classification Catalogue of Medical Devices" in 2023, the average registration period for Class II IVD products will be shortened to 14 months, and the utilization rate of the special approval channel for innovative products will increase by 60%. The "14th Five Year Plan" for the development of the medical equipment industry clearly proposes five major technological directions for key development, including microfluidic chips and single-molecule detection. Under policy guidance, the R&D investment intensity in related fields has reached 12.8%. At the level of quality supervision, the frequency of flight inspections conducted by the National Medical Products Administration has increased by 45% year-on-year, and the failure rate of flight inspections has decreased from 17% in 2019 to 6% in 2023, significantly improving the standardization level of the industry. It is worth noting that the IVD reagent UDI (Unique Identification) full process traceability system launched in 2024 will drive the industry into a new stage of digital supervision. Resonance between Capital Market and Industrial Innovation Under the background of deepening the registration system reform, the IPO financing in the IVD field reached 21.8 billion yuan in 2023, setting a new historical high. The average R&D investment of the 15 IVD companies listed on the Science and Technology Innovation Board accounts for 19%, significantly higher than the industry average. The strong support of the capital market drives enterprises to accelerate their layout: 1. In the field of molecular diagnostics, the localization rate of digital PCR equipment has exceeded 40% 2. Mass spectrometry detection field: Domestic enterprises have obtained 25 clinical mass spectrometry reagent registration certificates 3. Smart Laboratory: LIS system penetration rate increases to 78%, AI assisted diagnostic module installation increases by 150% annually Under the dual drive of policies and capital, the industry is forming a virtuous cycle of "innovative research and development clinical validation industrialization". In 2023, the number of PCT patent applications in the IVD field in China will reach 1562, with a year-on-year increase of 28%, of which technological breakthroughs in subdivisions such as infectious diseases detection and early screening of tumors will be particularly significant. Hubei Xindesheng Material Technology, as a well-established enterprise in IVD core raw materials, helps domestic molecular diagnostic equipment shorten the technological gap with imported products. Through the dual wheel drive of "raw materials+algorithms", Xindesheng is providing the industry with a bottom-up technology solution that combines cost advantages and quality breakthroughs.  

Population structure changes give rise to rigid demand The elderly population aged 60 and above in China has exceeded 280 million, and the per capita medical expenditure of this group is 3.2 times that of young adults, directly promoting the expansion of the chronic disease testing market at a compound annual growth rate of 18%. In the field of diabetes management, the market scale of blood glucose monitoring products reached 9.5 billion yuan, and the market penetration rate of CGMS rapidly increased from 5% in 2020 to 17% in 2023. The adjustment of the birth policy brings structural opportunities. In 2023, the sales of prenatal screening reagents increased by 31% year-on-year, and the genetic disease testing projects for newborns have covered more than 200 diseases. It is worth noting that the tumor early screening market has shown explosive growth, with sales of 800 million yuan in the first year of the launch of multi cancer joint detection products based on NGS technology. Upgrading health consumption drives market segmentation The per capita healthcare expenditure of residents has increased to 8.7% of consumption expenditure, giving rise to three major consumption trends: 1. Precise testing demand: The number of users for personalized drug genetic testing services has exceeded 5 million 2. Convenience demand: the annual growth rate of the household self-test product market reached 45%, and the COVID-19 antigen test continued to increase after normalization 3. Preventive testing: The penetration rate of cancer early screening products in the 35-50 age group has increased to 12% The upgrading of consumption is also reflected in the improvement of testing quality requirements. Third level hospitals require a coverage rate of 92% for the traceability ability of testing items, and as a result, the market size of quality control products maintains an annual growth rate of over 20%. In terms of payment ability, the number of testing projects covered by commercial health insurance has increased from 87 in 2019 to 215 in 2023, significantly expanding the high-end testing market space. Structural opportunities brought by healthcare system reform After the deepening implementation of the hierarchical diagnosis and treatment system, the number of testing projects carried out in primary medical institutions will increase by 38% year-on-year in 2023, promoting the continuous expansion of the POCT equipment market. The construction of medical consortia has led to the rise of regional testing centers, with 70% of county-level medical consortia achieving mutual recognition of testing results, driving the sinking of high-throughput testing equipment into the market. The DRG payment reform has forced medical institutions to optimize their testing processes. By 2023, the average testing turnover time (TAT) of tertiary hospitals will be reduced to 2.1 hours, an increase of 40% in efficiency compared to before the reform. This transformation directly stimulates the demand for automated assembly lines, with an annual increase of 65% in the installed capacity of laboratory automation systems (LAS) in China, and the maximum number of connected modules in a single laboratory reaching 12. Innovation in the Mode of Third Party Inspection Services The market concentration of ICL (Independent Medical Laboratory) continues to increase, with the top three companies accounting for 68% of the market share. There are three major development trends in the industry in 2023: 1. The proportion of special testing services has increased to 35%, with tumor gene testing and rare disease diagnosis becoming growth engines 2. Digital service upgrade, 88% of ICLs achieve mobile report query and intelligent interpretation 3. Extension of the industrial chain, leading enterprises begin to lay out accompanying diagnostic centers and precision treatment alliances Breakthroughs have been made in the construction of regional testing centers, with an average daily testing volume of over 100000 items in 23 provincial-level regional testing centers. The economies of scale have reduced the cost of single testing by 28%. In the field of emergency detection, the establishment of a pathogen monitoring network in 78 cities has shortened the response time for detecting new infectious diseases to 48 hours. Deep integration of technological innovation and clinical needs The clinical demand-oriented research and development model has achieved significant results: In the field of severe illness, the detection time of early diagnostic indicators for sepsis is advanced to 4 hours after the onset of symptoms Chronic disease management: the dynamic monitoring system based on wearable devices increased the compliance rate of diabetes control by 25% Tumor diagnosis and treatment: MRD (minimal residual lesion) detection technology achieves a recurrence monitoring sensitivity of 0.01% The collaborative innovation mechanism between medical institutions and enterprises is gradually improving. In 2023, 27 "Medical Engineering Cross Union Laboratories" will be established to promote the clinical translation of 15 innovative testing technologies. In terms of standard construction, the latest 23 industry standards, including the "Expert Consensus on Clinical Application of Liquid Chromatography Mass Spectrometry," have paved the way for the application of new technologies. Hubei Xindesheng Material Technology has built a comprehensive solution covering the entire diagnostic process, focusing on core products such as blood collection tube additives, biological buffering agents, and chromogenic substrates. Assist medical institutions in addressing the challenges of DRG payment reform. By continuously providing cost-effective raw material products, enterprises are becoming a solid support for the development of inclusive healthcare.

In the chemical industry, anionic surfactants are an important class of compounds with wide applications. They not only have excellent wetting, dispersing, emulsifying, foaming, and washing properties, but also play a key role in fields such as medicine, pesticides, textiles, cosmetics, and food industry. As a multifunctional compound, the biological buffer CAPSO buffer (3- (cyclohexylamine) -2-hydroxy-1-propanesulfonic acid) exhibits unique advantages in the preparation of anionic surfactants due to its unique chemical structure and properties. Basic properties of CAPSO CAPSO is a white powdery substance with good water solubility. The molecular structure of CAPSO contains both hydrophilic sulfonate groups and highly active hydroxyl groups, which makes it easy for CAPSO to undergo reactions such as detachment and substitution, thus endowing it with diversity as a functional substance. The advantages of CAPSO in preparing anionic surfactants 1. Environmental friendliness: CAPSO, as a biological buffering agent, is usually prepared using environmentally friendly raw materials and has mild reaction conditions, reducing the emission of harmful substances. 2. Efficiency: The active hydroxyl and sulfonate groups of CAPSO endow it with excellent reactivity, enabling the reaction to be completed in a relatively short time and improving production efficiency. 3. Multifunctionality: By adjusting the structure and reaction conditions of CAPSO, anionic surfactants with different properties and applications can be prepared to meet various application needs. 4. Biocompatibility: CAPSO, as a biological buffering agent, usually produces anionic surfactants with good biocompatibility, which are suitable for fields such as medicine, cosmetics, and food industry. Application examples The anionic surfactants prepared by CAPSO have shown broad application prospects in multiple fields. For example, in the detergent industry, alkyl sulfonate surfactants prepared by CAPSO have excellent washing performance and biodegradability, becoming an important component of environmentally friendly detergents. In the pesticide industry, anionic surfactants prepared by CAPSO can serve as synergists for pesticides, improving their adhesion and permeability, thereby enhancing their insecticidal efficacy and utilization rate. In the cosmetics industry, anionic surfactants prepared by CAPSO can be used as emulsifiers, dispersants, and stabilizers for the preparation of various cosmetic formulations. Conclusion In summary, the biological buffer CAPSO has unique application advantages and broad application prospects in the preparation process of anionic surfactants. By fully utilizing the chemical structure and properties of CAPSO, anionic surfactants with excellent performance and environmental characteristics can be prepared to meet various industrial application needs. In the future, with the deepening of the concepts of green chemistry and sustainable development, the application of CAPSO in the preparation of anionic surfactants will be further expanded and deepened. Desheng Biochemical is a professional manufacturer of CAPSO, with a series of products such as biological buffering agents available for everyone to choose from, as well as blood collection tube additives, luminescent reagents, and new Trinder's reagent series products. We have been developing and producing for 20 years now, with rich experience, skilled team, and guaranteed product quality. We will never let customers take the wrong path or waste money. And as a manufacturer direct sales, Desheng has a complete pre-sales and after-sales service, even if there are problems with the goods, we can solve them for you as soon as possible. If you have such needs, please click on the official website or call for consultation!

From April 24 to 26, 2025, the 32nd Türkiye Eurasia International Medical Exhibition EXPOMED EURASIA was successfully concluded in Istanbul T ü yap Exhibition Center. This medical industry event, which gathers over 1000 exhibitors and more than 35000 professional visitors, has become an important stage for Hubei Xindesheng Material Technology Co., Ltd. to showcase its strength, deepen cooperation, and look forward to the future. At this exhibition, Xindesheng showcased its full range of products and engaged in in-depth communication and cooperation with customers, leaving behind many exciting moments. The full range of products made a stunning debut, showcasing technical strength At the exhibition site, the full range of IVD reagent raw materials were neatly displayed in the booth (829C5) of Hubei Xindesheng Material Technology Co., Ltd., attracting the attention of many exhibitors. 1. The chemiluminescence series products are undoubtedly one of the focuses. Acridine ester, as a core raw material, has become a focus of attention for many customers due to its high purity and stable luminescence efficiency. Professional personnel explained in detail the mechanism of action of acridine ester in chemiluminescence immunoassay, as well as its application advantages in areas such as cancer biomarker detection and infectious disease diagnosis. From the synthesis process of raw materials to actual testing results, the multi angle display provides visitors with a visual and in-depth understanding of their performance. 2. The biological buffer series products have also attracted much attention. Tris, HEPES, Bicine and other buffering agents are arranged in an orderly manner, with detailed parameter explanations and application cases attached to each product. 3. The chromogenic substrate series products also shine brightly. TOOS, MAOS and other chromogenic substrates have become highlights at the exhibition due to their fast color development speed and low background values. In addition, the customized services provided by New Desheng to meet customer needs have also sparked a strong interest in personalized cooperation among many customers. Deep communication promotes cooperation and collaborates to explore new markets together During the exhibition, the booth of New Desheng maintained a warm atmosphere of communication. Customers from all over the world come in an endless stream, and the New Desheng team has engaged in in-depth communication and exchange with them with a professional attitude and enthusiastic service. In the face of various questions and demands raised by customers, the personnel of Xindesheng have provided detailed and professional answers. During the business negotiation phase, Xindesheng reached preliminary cooperation intentions with numerous clients and reached consensus on cooperation models, product specifications, and other aspects, preliminarily determining the cooperation framework. Through these exchanges and collaborations, Xindesheng not only expanded its market channels, but also gained a deeper understanding of the demand characteristics of customers in different regions, providing strong basis for subsequent product optimization and market layout. The exhibition has come to an end and started a new journey, forging ahead and composing a new chapter With the successful conclusion of Türkiye Medical Exhibition, Hubei Xindesheng Company has gained a lot. This exhibition not only enhanced the brand awareness of New Desheng, but also opened up a new situation for enterprises in overseas markets. The large amount of customer feedback and market demand information collected during the exhibition will become an important direction for the company's future product research and technological innovation. Since its establishment in 2005, Xindesheng has always focused on the field of IVD reagent raw materials. With modern production bases, professional R&D teams, and a sound quality control system, it continuously provides reliable quality products and services to the market. In the future, Xindesheng will take this exhibition as a new starting point, continuously strengthen technological innovation, optimize product performance, and improve service quality. Further deepen cooperation with customers at home and abroad, actively expand the market, and strive to contribute more to the development of the IVD diagnostic reagent raw material industry.

In today's rapidly advancing agricultural technology, plant hydroponics technology, as an efficient and environmentally friendly planting method, is gradually receiving widespread attention and application. Hydroponic technology provides necessary nutrients for plants by precisely controlling their growth environment, thereby achieving rapid and healthy growth. In this technological system, the selection of biological buffering agents is particularly crucial, and MOPS buffer (3-methylpropanesulfonic acid), as an excellent buffering agent, has demonstrated unique advantages in plant hydroponics. 1, MOPS: Master of acid-base balance in plant hydroponics The growth of plants has strict requirements for the pH value of the environment. In hydroponic systems, the pH value of the culture medium constantly changes due to the growth metabolism and nutrient consumption of plants. If the pH value deviates from the suitable growth range of plants, it will seriously affect the absorption and utilization of nutrients by plants, thereby affecting the growth rate and health status of plants. MOPS, as an efficient acid-base buffering agent, can provide stable buffering capacity over a wide pH range (usually 6.5-7.9), effectively neutralizing acid-base substances in the culture medium and maintaining pH stability. This stable acid-base environment provides a solid guarantee for the growth of plants, enabling them to carry out photosynthesis, nutrient absorption, and growth and development at their optimal state. 2, Multifunctionality: Comprehensive support from root fixation to nutrient supply The application of MOPS in plant hydroponics is not limited to acid-base balance, and its versatility is also one of the reasons why it is highly favored. Firstly, MOPS can serve as a fixative for plant roots, effectively fixing the roots through its viscous texture and suitable concentration, preventing them from floating or entangling in the culture medium, and improving the stability and absorption efficiency of the roots. Secondly, MOPS can also be used as a part of nutrient solutions to provide necessary nutrients for plants. Although MOPS itself does not directly provide major nutrients such as nitrogen, phosphorus, and potassium, it can form a complete nutrient solution system together with other nutrients, providing comprehensive nutritional support for plants. In addition, MOPS can also be used as a washing buffer to clean impurities and harmful substances on the surface of plant roots, keeping the roots clean and healthy. 3, Chemical stability: key to ensuring safe plant growth In plant hydroponics, chemical stability is one of the important indicators for measuring the performance of buffering agents. MOPS has excellent chemical stability and is not prone to chemical reactions with other components in the culture medium, thereby avoiding the generation of harmful substances and potential damage to plants. This chemical stability enables MOPS to maintain its buffering performance and nutrient stability in complex hydroponic environments, providing sustained and reliable support for plant growth. At the same time, MOPS does not form complexes with common metal ions such as copper, nickel, manganese, zinc, etc., avoiding the risk of toxicity to plants caused by high concentrations of metal ions. 4, Efficient dissolution and utilization: the key to improving the efficiency of nutrient solutions MOPS has good water solubility and can quickly dissolve and evenly disperse in water, forming a clear and transparent solution. This efficient solubility allows MOPS to mix evenly with other components in the hydroponic solution, improving the utilization rate of nutrient solution and the absorption efficiency of plant nutrients. This efficient dissolution and utilization characteristic enables MOPS to exert maximum efficiency in plant hydroponics, providing sufficient nutritional support for plant growth. In summary, the biological buffer MOPS has demonstrated unique advantages in plant hydroponics. Its stable acid-base balance ability, multifunctionality, chemical stability, efficient dissolution and utilization, as well as environmental protection and sustainability, make MOPS an indispensable and important component in plant hydroponic technology. With the continuous advancement of agricultural technology and the increasing demand for green and healthy agricultural products, the application prospects of MOPS in plant hydroponics will be even broader. Desheng is a professional manufacturer of biological buffering agents, established for more than ten years. It has rich experience in research and development, production, and product knowledge, and can provide customers with a large amount of technical support and after-sales guarantee. The biological buffer products currently produced include MOPS, TRIS, HEPES, TAPS, CAPS, BICINE, EPPS, PEP and a series of other biological buffer solutions. If you need them, please feel free to contact us at any time!